Bruno Marques has been building and leading the Process & Product Development team at Century Therapeutics since 2019. Prior to Century, Bruno spent 14 years developing and commercializing biopharmaceutical products at Merck and GlaxoSmithKline. At GSK, he held leadership roles in process development and portfolio management, contributing to the launch of drugs such as Nucala (mepolizumab), and eventually joined their Cell & Gene Therapy platform as Director of Manufacturing Strategy in support of autologous immunotherapies. Bruno is a Chemical Engineer by training, with a PhD from Carnegie Mellon University and a BS from the Illinois Institute of Technology.
